About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification.

Philochem has discovered innovative methodologies for biotechnology product development...>>

Recent News

Siena (Italy),
September 1st, 2014

Philogen announces unprecedented pre-clinical activity for Tetravil, a novel biopharmaceutical therapeutic agent for the therapy of rheumatoid arthritis.
Please see Tetravil Press Release for more information.

Upcoming Events

San Diego (USA),
27th-28th October, 2104

Dr. Giulio Casi will present "Arming disease-targeting antibodies with cytotoxic drugs and with cytokines" at World ADC Conference.